BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21220599)

  • 1. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
    Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
    J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
    [No Abstract]   [Full Text] [Related]  

  • 2. Richter's transformation of chronic lymphocytic leukemia.
    Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
    J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
    [No Abstract]   [Full Text] [Related]  

  • 3. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
    Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
    Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
    Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
    Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.
    Zinzani PL; Broccoli A; Stefoni V; Musuraca G; Abruzzese E; De Renzo A; Cantonetti M; Bacci F; Baccarani M; Pileri SA
    Cancer; 2010 Dec; 116(24):5667-75. PubMed ID: 20737566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient with high-grade fever, night sweats, and hepatosplenomegaly.
    Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H
    J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615
    [No Abstract]   [Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma presenting as pancoast tumor.
    Ngamphaiboon N; Pukiat S; Kandimalla Y; Hernandez-Ilizaliturri FJ; Rooney JJ
    J Clin Oncol; 2010 Jun; 28(16):e254-6. PubMed ID: 20385989
    [No Abstract]   [Full Text] [Related]  

  • 11. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
    Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
    J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
    Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
    [No Abstract]   [Full Text] [Related]  

  • 13. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
    Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
    Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular lymphoma.
    Thomas LC; Adonizio C; Filicko-O'Hara J; Golshayan AR; Costa LJ; Morris GJ
    Semin Oncol; 2010 Dec; 37(6):549-54. PubMed ID: 21167372
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
    Lai S; Venugopal P; Leslie W
    Clin Adv Hematol Oncol; 2012 Feb; 10(2):134-6. PubMed ID: 22402359
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
    Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
    Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2010 May; 149(3):310. PubMed ID: 20085576
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
    Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
    Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary diffuse large B cell lymphoma of the base of tongue.
    Lim JH; Lim JY; Kim YM; Kim CS; Choi SJ; Yi HG; Choi WG; Lee MH
    J Cancer Res Ther; 2012; 8(1):135-7. PubMed ID: 22531534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
    Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
    Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.